A team from ETH Zurich and Karolinska Institutet has developed a cross-linking MALDI mass spectrometry workflow that captures both functional response and target binding in a single assay. Drug screening has traditionally been split between functional assays and binding assays. However, neither tells the full story. Functional assays indicate whether a drug works, but not…
